breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
* | USA300TCH1516_ALE | 111,512 | 0 | A | G | 40.0% | 34.4 / 51.7 | 45 | S194S (TCA→TCG) | USA300HOU_RS00520 | putative lipoprotein |
* | USA300TCH1516_ALE | 111,516 | 0 | C | A | 38.3% | 72.0 / 47.7 | 47 | Q196K (CAA→AAA) | USA300HOU_RS00520 | putative lipoprotein |
* | USA300TCH1516_ALE | 110,660 | 0 | T | A | 26.8% | 77.2 / 33.1 | 41 | I173I (ATT→ATA) | USA300HOU_RS00515 | putative lipoprotein |
* | USA300TCH1516_ALE | 602,466 | 0 | G | T | 25.0% | 123.4 / 13.8 | 52 | intergenic (+56/‑104) | hchA/araB | Molecular chaperone Hsp31 and glyoxalase 3/Ribulokinase |